Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study.,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study.
Antiviral Therapy ( IF 1.2 ) Pub Date : 2018-1-6 , DOI: 10.3851/imp3218
Lars Peters ₁ , Amanda Mocroft ₂ , Daniel Grint ₃ , Santiago Moreno ₄ , Alexandra Calmy ₅ , Djordje Jevtovic ₆ , Helen Sambatakou ₇ , Karine Lacombe ₈ , Stephane De Wit ₉ , Jürgen Rockstroh ₁₀ , Jelena Smidt ₁₁ , Igor Karpov ₁₂ , Anna Grzeszczuk ₁₃ , Vesnadarjan Haziosmanovic ₁₄ , Magnus Gottfredsson ₁₅ , Roxana Radoi ₁₆ , Elena Kuzovatova ₁₇ , Chloe Orkin ₁₈ , Anna Lisa Ridolfo ₁₉ , Jose Zapirain ₂₀ , Jens Lundgren ₁

Affiliation

CHIP, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
University College London Medical School, Primary Care and Population Sciences, London, United Kingdom.
London School of Hygiene and Tropical Medicine, Department of Infectious Disease Epidemiology, London, United Kingdom.
Hospital Universitario Ramón y Cajal-IRYCIS, Infectious Diseases Department, Madrid, Spain.
University Hospital Geneva, Geneva, Switzerland.
The Institute for Infectious & Tropical Diseases, Belgrade, Serbia.
Athens Medical School, Hippokration General Hospital, Athens, Greece.
Hopital Saint-Antoine, Paris, France.
CHU Saint-Pierre Hospital, Brussels, Belgium.
University of Bonn, Department of Medicine I, Bonn, Germany.
Narva AIDS Centre, Kohtla-Järve, Estonia.
Belarus State Medical University, Minsk, Belarus.
Uniwersytet Medyczny w Bialymstoku, Department of Infectious Diseases, Bialystok, Poland.
Klinicki Centar Univerziteta Sarajevo, Sarajevo, Bosnia & Herzegovina.
University of Iceland and Landspitali University Hospital, Reykjavik, Iceland.
Dr. Victor Babes Hospital, Spitalul de Boli Infectioase si Tropicale, Bucharest, Romania.
Nizhny Novgorod Scientific and Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia.
Royal London Hospital, London, United Kingdom.
Osp. L. Sacco, Milan, Italy.
Hospital Universitario de Alava, Vitoria-Gasteiz, Spain.

According to guidelines all HIV-HBV-coinfected patients should receive tenofovir-based combination antiretroviral therapy (cART). We aimed to investigate uptake and outcomes of tenofovir-based cART among HIV-HBV patients in the EuroSIDA study.

中文翻译：

EuroSIDA 研究中 HIV-HBV 合并感染患者接受基于替诺福韦的抗逆转录病毒治疗。

根据指南，所有 HIV-HBV 合并感染患者均应接受基于替诺福韦的联合抗逆转录病毒治疗 (cART)。我们旨在调查 EuroSIDA 研究中基于替诺福韦的 cART 在 HIV-HBV 患者中的摄取和结果。

更新日期：2020-08-21

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>